Jeremy Grushcow at The Cross-Border Biotech Blog breaks down how the recent amendments to Canada’s insolvency legislation pertain to intellectual property licenses. He writes that unlike in the U.S., where Section 365 (n) of the bankruptcy code protects licensees in the event that that licensor becomes insolvent, Canadian law has not offered such protection in the past.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.